GlassScriptPhysician profile
Neeraj Kohli
NPI 1003872227
$17,036.15
in general payments reported to CMS, 2019-2025
22 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 85% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,179 · 2020: $302 · 2021: $3,115 · 2022: $10K · 2023: $760 · 2024: $524 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543 · Travel and Lodging: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.28 |
| Travel and Lodging | $798.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $12,765.86 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,274.47 | 2021-2025 | Interstim |
| Hologic Sales and Service, LLC | $600.00 | 2021 | |
| Coloplast Corp | $344.94 | 2019-2022 | |
| Astellas Pharma US INC | $266.27 | 2019-2021 | |
| Therapeuticsmd, INC. | $188.25 | 2019-2021 | |
| Pfizer INC. | $167.73 | 2019-2022 | |
| Gynesonics, INC. | $167.39 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Caldera Medical, INC | $165.01 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $162.28 | 2019 | |
| Medtronic USA, INC. | $158.43 | 2019 | |
| Abbvie INC. | $143.36 | 2023-2025 | |
| Boston Scientific Corporation | $126.36 | 2019-2025 | Advantage System, Axonics |
| Minerva Surgical, INC | $103.45 | 2022-2023 | |
| Allergan, INC. | $101.95 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $93.80 | 2019 | |
| Scynexis, INC. | $92.07 | 2022 | |
| Contura, INC. | $38.15 | 2020 | |
| Escala Medical INC. | $22.50 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $19.43 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.23 | 2025 | |
| Amag Pharmaceuticals, INC. | $17.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeraj Kohli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.